Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ERIC JONASCH and IAN E MCCUTCHEON.
ERIC JONASCH
Connection Strength
0.619
IAN E MCCUTCHEON
  1. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol. 2018 10; 19(10):1351-1359.
    View in: PubMed
    Score: 0.170
  2. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas. Cancer Res. 2017 10 01; 77(19):5313-5326.
    View in: PubMed
    Score: 0.157
  3. Key considerations in the treatment of von Hippel-Lindau disease. Future Oncol. 2016 Aug; 12(15):1755-8.
    View in: PubMed
    Score: 0.143
  4. Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report. Target Oncol. 2012 Jun; 7(2):145-9.
    View in: PubMed
    Score: 0.108
  5. Pilot study of dovitinib in patients with von Hippel-Lindau disease. Oncotarget. 2018 May 04; 9(34):23390-23395.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.